Inventiva S.A. (IVA) stock
IVANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as IVEVF
$3.68−0.20 (-5.15%)
Close on Nov 13, 2026Market cap $711.11MP/E –Yield –
Inventiva enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Inventiva's enterprise value was $762.19M on Nov 11, 2026, against $449.78M a year earlier. Over the last 5 years it ranged from $56.95M to $1.14B, with a median of $178.21M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $762.19M | +51.3% |
| 2025 | Dec 31, 2025 | $503.79M | +394.9% |
| 2024 | Dec 31, 2024 | $101.80M | -46.8% |
| 2023 | Dec 29, 2023 | $191.50M | +90.5% |
| 2022 | Dec 30, 2022 | $100.53M | -76.0% |
| 2021 | Dec 31, 2021 | $419.45M | +41.1% |
| 2020 | Dec 31, 2020 | $297.35M | – |
See a number that looks wrong?